Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YZJ-4729 for Moderate to Severe Pain After Orthopedic Surgery
NCT06901830Phase 2Completed
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- Start
- May 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of YZJ-4729 in acute postoperative pain (5 arms), sponsored by Shanghai Haiyan Pharmaceutical Technology Co., Ltd. Primary endpoint: Sum of Pain Intensity Differences over 48 hours at rest. Started May 2025; status: completed.
02
Drugs
YZJ-4729
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT06901830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06901830.